Joanne Elizabeth Compson

Title: Joanne Elizabeth Compson: Innovator in Antibody Therapeutics

Introduction

Joanne Elizabeth Compson is a prominent inventor based in Slough, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to her name, her work focuses on innovative solutions for treating various diseases, including lung fibrosis.

Latest Patents

One of her latest patents involves antagonist antibodies that bind to human TGFB1, TGFB2, and TGFB3, aimed at treating lung fibrosis. This patent details TGF-beta antibodies and their binding fragments, along with the DNA encoding these antibodies. It also discusses host cells that comprise this DNA and methods for expressing the antibody or binding fragment in a host cell. Furthermore, the disclosure extends to pharmaceutical compositions that include the antibody or its binding fragments, emphasizing their use in treating diseases such as fibrosis.

Career Highlights

Throughout her career, Joanne has worked with notable companies in the biotechnology sector, including UCB Biopharma Srl and UCB Biopharma Sprl. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.

Collaborations

Joanne has collaborated with esteemed colleagues, including Daniel John Lightwood and Andrew Charles Payne. These partnerships have enriched her research and expanded the impact of her inventions in the field.

Conclusion

Joanne Elizabeth Compson is a trailblazer in the development of antibody therapeutics, with a focus on addressing critical health challenges. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.